Exhaled Nitric Oxide Level in Pharynx Angioedema.

Area of Science:

• Pulmonology
• Allergy and Immunology
• Respiratory Medicine

Background:

• Airway inflammation is linked to elevated nitric oxide production, measurable noninvasively via exhaled nitric oxide.
• Chronic urticaria and angioedema are conditions where airway inflammation was previously suspected.
• Exhaled nitric oxide measurement serves as a noninvasive marker for assessing airway inflammation.

Purpose of the Study:

• To investigate the presence of airway inflammation in patients with chronic urticaria and pharynx angioedema.
• To determine if symptomatic chronic urticaria patients with pharynx angioedema exhibit increased exhaled nitric oxide levels compared to healthy controls.
• To evaluate the utility of exhaled nitric oxide measurement in assessing airway inflammation in this specific patient population.

Main Methods:

• A study group of 26 symptomatic chronic urticaria patients with acute pharynx angioedema was recruited.
• A control group of 29 non-smoking healthy subjects without atopy was included for comparison.
• Exhaled nitric oxide levels were measured noninvasively in all participants.

Main Results:

• Exhaled nitric oxide levels in the angioedema group were measured at 15.5 ppb.
• Exhaled nitric oxide levels in the healthy control group were measured at 17.0 ppb.
• Statistical analysis revealed no significant difference in exhaled nitric oxide levels between the two groups.

Conclusions:

• The findings suggest a lack of significant airway inflammation in patients suffering from chronic urticaria with pharynx angioedema.
• Exhaled nitric oxide measurement did not indicate increased airway inflammation in this patient cohort.
• Further research may be warranted to explore other potential mechanisms or inflammatory markers in chronic urticaria and angioedema.